FDA GMP Quality Metrics Will Be Industry’s ‘SAT Score’
This article was originally published in The Pink Sheet Daily
Executive Summary
Number 2 pencils will not be required, but FDA hopes the reports will make purchasing decisions resemble the college admissions process to some extent.
You may also be interested in...
FDA To Update Quality Metrics Guidance
It's the only addition to the agency's 2016 agenda.
FDA To Update Quality Metrics Guidance
It's the only addition to the agency's 2016 agenda.
Pink Sheet Podcast: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial failed, an FDA idea to bring potential biomarkers for promising allergy and asthma treatments to advisory committees, and Japan’s PMDA opening an office in Washington D.C.